News
Award of Share Options
27 April 2012
TyraTech, Inc. (AIM: TYR), a natural life sciences company, announces that on 25 April 2012, a total of 3,965,000 Stock Appreciation Right options over common shares of US$0.001 in the Company ("SARs"), were awarded to 20 employees and the directors of the Company (the "Award").
Of the SAR's awarded, Alan Reade, James Hills, Barry Riley and Dr. Kevin Schultz, directors of the Company, were awarded 1,000,000, 350,000, 350,000 and 100,000 SARs, respectively.
The Company now has a total of 8,176,909 SARs outstanding over Common shares at an average exercise price of 18p.
Following the Award:
Alan Reade is interested in 7,561,358 Common Shares representing an interest of 7.03 per cent. of the total voting rights of the Company. In addition, Alan Reade is interested in 2,645,695 SARs in the Company as follows:
| Options Held | Option Exercise Price | Expiry Date |
| 1,000,000 | 6p | 25 April 2022 |
| 100,570 | 12p | 6 March 2022 |
| 550,000 | 10.5p | 4 February 2020 |
| 995,125 | 12p | 10 October 2020 |
James Hills is interested in 365,500 Common Shares in the Company representing an interest of up to 0.34 per cent. of the total voting rights of the Company. In addition, James Hills is interested in 550,000 SARs in the Company as follows:
| Options Held | Option Exercise Price | Expiry Date |
| 350,000 | 6p | 25 April 2022 |
| 200,000 | 12p | 10 October 2020 |
Barry Riley is interested in 2,255,556 Common Shares in the Company representing an interest of up to 2.10 per cent. of the total voting rights of the Company. In addition, Barry Riley is interested in 550,000 SARs in the Company as follows:
| Options Held | Option Exercise Price | Expiry Date |
| 350,000 | 6p | 25 April 2022 |
| 200,000 | 12p | 10 October 2020 |
Dr. Kevin Schultz is interested in 300,000 SARs in the Company as follows:
| Options Held | Option Exercise Price | Expiry Date |
| 100,000 | 6p | 25 April 2022 |
| 200,000 | 12p | 20 October 2020 |
For further information please contact:
TyraTech Inc.
Alan Reade, Executive Chairman
Tel: +1 919 415 4310
Peter Jerome, Chief Financial Officer
Tel: +1 919 415 4280
N+1 Brewin, Nominated Adviser and Joint Broker
Aubrey Powell/ Robert Beenstock
Tel: +44 20 3201 3170
First Columbus LLP, Joint Broker
Chris Crawford
Tel: +44 20 3002 2070
Disclaimer for U.S. Site Visitors
This web site contains investor-related information which is restricted to non-U.S. persons or Qualified Institutional Buyers as defined in Rule 144A of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The information provided herein is not an offer to buy or sell, or a solicitation of an offer to buy or sell, any TyraTech, Inc. securities. By viewing pages on this web site, you agree and acknowledge that TyraTech, Inc.'s common stock has not been registered under the Securities Act and that you are a non-U.S. person, Qualified Institutional Buyer as defined in Rule 144A of the Securities Act., or you are not holding, acquiring or selling TyraTech, Inc. common stock for the account or benefit of any U.S. person.